-
1.
公开(公告)号:US20190255083A1
公开(公告)日:2019-08-22
申请号:US16403095
申请日:2019-05-03
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
2.
公开(公告)号:US20170136049A1
公开(公告)日:2017-05-18
申请号:US15419241
申请日:2017-01-30
IPC分类号: A61K31/702 , A23L2/52 , A23L33/00 , A23L33/10
CPC分类号: A61K31/702 , A23L2/52 , A23L33/10 , A23L33/21 , A23L33/28 , A23L33/40 , A23V2002/00 , C07H3/06 , Y02A50/473 , Y02A50/481
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
3.
公开(公告)号:US10286001B2
公开(公告)日:2019-05-14
申请号:US15419241
申请日:2017-01-30
摘要: The invention provides compositions and methods for utilizing synthetic human milk oligosaccharides as prebiotics.
-
公开(公告)号:US20150265661A1
公开(公告)日:2015-09-24
申请号:US14391739
申请日:2013-03-13
发明人: David S. Newburg , Zhuoteng Yu
IPC分类号: A61K35/745 , A23L1/29 , A23L1/30 , A61K31/717 , A61K31/702
CPC分类号: A61K35/745 , A23L33/10 , A23L33/135 , A23L33/30 , A23V2002/00 , A23Y2300/45 , A23Y2300/55 , A61K31/702 , A61K31/717 , Y02A50/473 , A61K2300/00
摘要: Provided herein are prebiotic compositions comprising a combination of oligosaccharides such as sialyated oligosaccharides and fusocylated oligosaccharides, and uses thereof in stimulating the proliferation of beneficial intestinal micro biota, for example, of bifidobacteria, and/or in decreasing the abundance of enteric pathogens. The prebiotic compositions can further contain a probiotic, which can be a population of bifidobacteria, lactobacilli, Bacteriodes fragilis, Bacteriodes thetaiotaomicron, Enterococcus faecalis (pro biotic strains thereof), Staphylococcus epidermides, Enterobacter aerogenes, Enterobacter cloacae, or related bacteria having similar functions.
摘要翻译: 本文提供的益生元组合物包含低聚糖如唾液酸化低聚糖和融合寡糖的组合,以及其在刺激有益肠微生物群(例如双歧杆菌)和/或减少肠道病原体丰度方面的用途。 益生元组合物可以进一步含有益生菌,其可以是双歧杆菌,乳杆菌,脆弱细菌,大肠杆菌,粪肠球菌(其生物菌株),表皮葡萄球菌,产气肠杆菌,阴沟肠杆菌或具有相似功能的相关细菌的群体。
-
公开(公告)号:US11324766B2
公开(公告)日:2022-05-10
申请号:US17320003
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61K9/00 , A61K45/06 , A61K35/745 , A61K35/742 , A61K35/74 , A23L33/125 , A23L33/00 , A23L2/52 , A61K35/747
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection-induced host inflammation and/or to promote recovery from a respiratory pathogen infection-induced host inflammation in a subject.
-
公开(公告)号:US20210353654A1
公开(公告)日:2021-11-18
申请号:US17320152
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61P31/14 , A23L33/125 , A23C9/20
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.
-
公开(公告)号:US11331329B2
公开(公告)日:2022-05-17
申请号:US17320152
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61P31/14 , A23C9/20 , A23L33/125
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection and/or to promote recovery from a respiratory pathogen infection in the respiratory system and/or the GI tract of a subject.
-
公开(公告)号:US20210353653A1
公开(公告)日:2021-11-18
申请号:US17320003
申请日:2021-05-13
申请人: Glycosyn LLC
IPC分类号: A61K31/702 , A61K9/00 , A61K45/06 , A61K35/745 , A61K35/747 , A61K35/742 , A61K35/74 , A23L33/125 , A23L33/00 , A23L2/52
摘要: The invention provides compositions and methods for utilizing oligosaccharides, such as isolated human milk oligosaccharides, to attenuate a respiratory pathogen infection-induced host inflammation and/or to promote recovery from a respiratory pathogen infection-induced host inflammation in a subject.
-
-
-
-
-
-
-